PlainRecalls
FDA Drug Critical Class I Terminated

HYDROMORPHONE HCL-BUPIVACAINE HCL-CLONIDINE HCL PF INJECTABLE 21 mL syringes in two strengths: a) 20MG-20MG-60MCG/ML INJECTABLE, b) 5MG-5MG-100MCG/ML, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605

Reported: August 18, 2021 Initiated: October 5, 2020 #D-0709-2021

Product Description

HYDROMORPHONE HCL-BUPIVACAINE HCL-CLONIDINE HCL PF INJECTABLE 21 mL syringes in two strengths: a) 20MG-20MG-60MCG/ML INJECTABLE, b) 5MG-5MG-100MCG/ML, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605

Reason for Recall

Non-Sterility

Details

Recalling Firm
Med Shop Total Care Inc.
Units Affected
42 mL
Distribution
Texas and Puerto Rico
Location
Longview, TX

Frequently Asked Questions

What product was recalled?
HYDROMORPHONE HCL-BUPIVACAINE HCL-CLONIDINE HCL PF INJECTABLE 21 mL syringes in two strengths: a) 20MG-20MG-60MCG/ML INJECTABLE, b) 5MG-5MG-100MCG/ML, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605. Recalled by Med Shop Total Care Inc.. Units affected: 42 mL.
Why was this product recalled?
Non-Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on August 18, 2021. Severity: Critical. Recall number: D-0709-2021.